Asbestosis full details for md exams 15marks answer

Reading File

Finding Sources

Reading File

Loading Image

Asbestosis: 15-mark MD exam answer

Definition

Asbestosis is a chronic, diffuse interstitial fibrosing lung disease caused by inhalation and retention of asbestos fibers, especially after prolonged occupational exposure and long latency. It is a form of pneumoconiosis.

Etiology and risk exposures

Common high-risk occupations:

Mining and milling of asbestos
Shipyard work
Insulation work
Construction, demolition, asbestos cement industry
Brake/lining manufacture and repair
Textile and roofing industries

Risk is related to:

Fiber burden (intensity x duration)
Fiber type (amphiboles are more fibrogenic and biopersistent than chrysotile)
Time since first exposure (typically decades)

Pathogenesis

Inhaled fibers deposit at respiratory bronchioles/alveolar ducts.
Fibers migrate into interstitium and trigger macrophage alveolitis.
Incomplete clearance leads to persistent inflammation.
Macrophages release cytokines and oxidants (TNF-alpha, IL-1, growth factors, ROS) causing fibroblast activation and collagen deposition.
Progressive peribronchiolar fibrosis extends to diffuse interstitial fibrosis and honeycombing in advanced disease.

Key concept: disease may progress even after exposure stops due to retained fibers.

Pathology

Gross:

Predominantly lower-lobe, subpleural fibrosis
Small stiff lungs in advanced stage
Pleural thickening/plaques may coexist

Microscopy:

Early peribronchiolar fibrosis with chronic interstitial inflammation
Type II pneumocyte hyperplasia
Hallmark: asbestos bodies (ferruginous bodies): golden-brown, beaded/clubbed rods with iron-protein coating
Advanced disease: diffuse interstitial fibrosis and honeycombing

Clinical features

Long latency: usually 10 to 20+ years after first exposure
Progressive exertional dyspnea (most common)
Dry cough
Bibasal fine end-inspiratory crackles (classically persistent)
Clubbing in some cases
Late: respiratory failure, pulmonary hypertension/cor pulmonale

Imaging findings

Chest X-ray:

Bilateral lower-zone irregular/reticular opacities
May show shaggy heart border in basal fibrosis
Pleural plaques support asbestos exposure

HRCT (more sensitive):

Subpleural curvilinear lines
Intralobular/interlobular septal thickening
Parenchymal bands
Early honeycombing (advanced disease)
Pleural plaques, pleural thickening, rounded atelectasis
Better than CXR for early disease detection

Pulmonary function tests

Typical:

Restrictive ventilatory defect (reduced FVC, TLC)
Reduced DLCO
Hypoxemia in advanced disease Mixed restrictive-obstructive pattern can occur, especially with airway involvement or smoking.

Diagnostic approach

Diagnosis is clinicoradiologic with exposure linkage:

Definite occupational/environmental asbestos exposure history
Compatible latency
Typical imaging (especially lower-lobe interstitial fibrosis +/- pleural disease)
PFT support (restriction +/- low DLCO)
Exclusion of other ILDs (IPF, CTD-ILD, chronic HP, silicosis, etc.)

Histology/lung biopsy is not routinely needed if exposure plus radiology are typical; consider when diagnosis is uncertain.

Differential diagnosis

Idiopathic pulmonary fibrosis (UIP)
Other pneumoconioses (silicosis, coal worker pneumoconiosis)
Chronic hypersensitivity pneumonitis
CTD-associated ILD
Drug/radiation-induced fibrosis
Sarcoidosis (fibrotic stage)

Complications

Progressive respiratory insufficiency
Pulmonary hypertension and cor pulmonale
Pleural disease: plaques, diffuse pleural fibrosis, benign pleural effusions
Malignancy:
- Bronchogenic carcinoma (strongly increased with smoking; multiplicative interaction)
- Malignant mesothelioma
- Other asbestos-associated cancers (e.g., laryngeal, ovarian)

Management

No curative antifibrotic treatment is established specifically for asbestosis in standard texts.

Principles:

Immediate cessation of further exposure
Smoking cessation (critical)
Vaccination (influenza, pneumococcal as indicated)
Bronchodilators if airflow limitation
Pulmonary rehabilitation
Long-term oxygen therapy when hypoxemic
Treat complications (pulmonary HTN, infections, failure)
Surveillance for lung cancer/mesothelioma in high-risk individuals
Occupational health notification, compensation, and preventive workplace control

Prognosis

Variable; mild disease may remain stable
Progressive decline can occur, including after exposure ceases
Prognosis worsens with heavy cumulative exposure, advanced fibrosis, and malignancy
Major causes of mortality: respiratory failure, lung cancer, mesothelioma

High-yield exam add-ons (to score better)

Earliest pathology: peribronchiolar fibrosis at respiratory bronchioles/alveolar ducts
Distribution: lower-lobe and subpleural predominance (unlike silicosis upper-zone tendency)
Diagnostic hallmark: asbestos bodies on histology
Most common pleural manifestation: pleural plaques
Most feared malignancies: bronchogenic carcinoma and mesothelioma
Smoking interaction: markedly magnifies lung cancer risk in exposed workers

Image (classic asbestos body + pleural plaques)

Asbestosis histology and pleural plaques

Textbook basis

Fishman’s Pulmonary Diseases and Disorders, chapter on Asbestosis (pathology, pathogenesis, PFT, imaging, treatment/prognosis)
Murray and Nadel’s Textbook of Respiratory Medicine, asbestos-related fibrosis section (clinical, radiology, diagnosis, natural history)
Robbins Pathologic Basis of Disease, pneumoconioses chapter (morphology, asbestos bodies, clinicopathologic correlation)

If you want, I can also give you a 1-page last-minute revision format (definition -> etiopathogenesis -> clinicoradiology -> diagnosis -> management -> complications) for quick recall before exam.

This is a shared conversation. Sign in to Orris to start your own chat.